BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 7892276)

  • 1. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.
    McGlynn KA; Rosvold EA; Lustbader ED; Hu Y; Clapper ML; Zhou T; Wild CP; Xia XL; Baffoe-Bonnie A; Ofori-Adjei D
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2384-7. PubMed ID: 7892276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of plasma aflatoxin B1-albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S-transferase M1 and T1.
    Chen SY; Chen CJ; Tsai WY; Ahsan H; Liu TY; Lin JT; Santella RM
    Nutr Cancer; 2000; 38(2):179-85. PubMed ID: 11525595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma.
    Chen CJ; Yu MW; Liaw YF; Wang LW; Chiamprasert S; Matin F; Hirvonen A; Bell DA; Santella RM
    Am J Hum Genet; 1996 Jul; 59(1):128-34. PubMed ID: 8659516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand.
    Hollstein MC; Wild CP; Bleicher F; Chutimataewin S; Harris CC; Srivatanakul P; Montesano R
    Int J Cancer; 1993 Jan; 53(1):51-5. PubMed ID: 8380058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the detoxication gene gstM1-gstT1-null and susceptibility to aflatoxin B1 related hepatocellular carcinoma in Guangxi].
    Long XD; Ma Y; Wei YP; Deng ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Oct; 26(10):777-81. PubMed ID: 16536303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study about the association of detoxication gene GSTM1 polymorphism and the susceptibility to aflatoxin B1-related hepatocellular carcinoma].
    Long XD; Ma Y; Wei YP; Deng ZL
    Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):668-70. PubMed ID: 16174455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
    Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC
    Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
    Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
    Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
    Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
    Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
    Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in aflatoxin-albumin adduct levels and effects of hepatitis B and C virus infection and glutathione S-transferase M1 and T1 genotype.
    Ahsan H; Wang LY; Chen CJ; Tsai WY; Santella RM
    Environ Health Perspect; 2001 Aug; 109(8):833-7. PubMed ID: 11564620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma.
    Tiemersma EW; Omer RE; Bunschoten A; van't Veer P; Kok FJ; Idris MO; Kadaru AM; Fedail SS; Kampman E
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):785-91. PubMed ID: 11440964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan.
    Sun CA; Wang LY; Chen CJ; Lu SN; You SL; Wang LW; Wang Q; Wu DM; Santella RM
    Carcinogenesis; 2001 Aug; 22(8):1289-94. PubMed ID: 11470760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?
    Hoque A; Patt YZ; Yoffe B; Groopman JD; Greenblatt MS; Zhang YJ; Santella RM
    Nutr Cancer; 1999; 35(1):27-33. PubMed ID: 10624703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
    Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
    Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China.
    Long XD; Ma Y; Qu DY; Liu YG; Huang ZQ; Huang YZ; Lin ZH; Wei NB; Zhou SC
    Ann Epidemiol; 2008 Jul; 18(7):572-8. PubMed ID: 18504145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and genetic epidemiology of hepatocellular carcinoma: studies in China and Senegal.
    London WT; Evans AA; Buetow K; Litwin S; McGlynn K; Zhou T; Clapper M; Ross E; Wild C; Shen FM
    Princess Takamatsu Symp; 1995; 25():51-60. PubMed ID: 8875609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.